On the last day, the Ravelcare IPO subscribed 437.60 times overall, while the retail quota subscribed 463.13 times, the QIB subscribed 155.91 times, and the NII quota subscribed 752.16 times, respectively.
Ravelcare IPO Details
Ravelcare got approval from SEBI for the IPO of ₹24.10 crore, which is an entirely fresh issue with a face value of ₹10 each share. It has a set price band of ₹123 to ₹130 per share.
Ravelcare Funds Utilisations
- The proceeds raised from the fresh issue will be utilized for Marketing and advertisement expenses toward enhancing the awareness and visibility of the brand.
- Some funds will be used for the Setting up a new manufacturing facility located at Mauje-Peth in Amravati (“Proposed facility”).
- Lastly, the remaining funds will be used for General Corporate Purposes.
Ravelcare Shares Distributions
Moreover, the retail category had 2,000 shares in a 2-lot size with a minimum application and a maximum.
S-HNI Minimum got 3,000 shares in 3 lot sizes.
S-HNI maximum got 7000 shares in 7 lot sizes.
B-HNI Minimum got 8000 shares in 8 sizes.
To participate in this IPO, each investor group has a tailored investment range.
- Retail Minimum & Maximum application:- ₹2,60,000.
- S-HNI Minimum:-₹3,90,000.
- S-HNI Maximum: 9,10,000.
- B-HNI Minimum: ₹10,40,000.
Ravelcare Subscription Duration
Ravelcare IPO Started on December 1, 2025, and closed on December 3, 2025. The allotment was on December 4, 2025, and non-allottees got a refund on December 5, 2025. Ravelcare’s IPO listing is on December 8, 2025.
About Ravelcare IPO
Ravelcare Ltd. was founded in November 2018 and is one of the growing beauty and personal care brands that is involved in providing a wide range of haircare, skincare, bodycare, and scalp-care products. Ravelcare sells its products through its own website and via other E-commerce websites like Amazon, Flipkart, Myntra, and Blinkit too.
The company’s main aim is to develop high-quality products that will meet the requirements of each of its customers. Moreover, the company handles its own logistics and warehousing in order to provide smooth and on-time delivery. Ravelcare is also planning to build a manufacturing facility with a capacity of 1,050 TPA in Mauje-Peth, Amravati, Maharashtra.
